37469-24-2Relevant articles and documents
Synthesis, characterization, DFT and TD-DFT study of novel bis(5,6-diphenyl-1,2,4-triazines)
Abou Kana, Maram T. H.,Ebeid, El-Zeiny M.,El-Daly, Samy A.,Elwahy, Ahmed H. M.,Mohamed, Adel A.,Sakr, Mahmoud A. S.
, (2021)
Due to the numerous biological as well as pharmacological activities of 1,2,4-triazine derivatives, we reported a synthesis of novel series of bis(5,6-diphenyl-1,2,4-triazines) via alkylation of 5,6-diphenyl-1,2,4-triazine-3(4H)-thione with the appropriate bis(halo) compounds in ethanolic KOH. The chemical structures of these compounds were confirmed by spectroscopic techniques. The absorption and excited-emission spectra of the studied novel series were monitored experimentally in ethanol solvent. The molecular structures of these triazines were optimized using B3LYP/6–31G(d) level of theory. The electronic absorption and emission spectra of the novel compounds, in gas and ethanol solvent, were calculated using time dependent density functional theory (TDDFT) at mPW1PW91/ 6–31 G (d) level. The obtained theoretical results were compared to experimental ones. The results show that, the computational optical properties of the studied novel series are in agreement with experimental results.
Diphenyl triazine hybrids inhibit α-synuclein fibrillogenesis: Design, synthesis and in vitro efficacy studies
Maqbool, Mudasir,Gadhavi, Joshna,Hivare, Pravin,Gupta, Sharad,Hoda, Nasimul
, (2020)
Aggregation of α-synuclein (α-syn) is one of the central hypotheses for Parkinson's disease (PD), therefore, its inhibition and disaggregation is an optimistic approach for the treatment of PD. Here, we report design, synthesis and in-vitro efficacy studi
Synthesis and screening of (E)-3-(2-benzylidenehydrazinyl)-5,6-diphenyl-1,2,4-triazine analogs as novel dual inhibitors of α-amylase and α-glucosidase
Alhowail, Ahmad,Ali, Muhammad,Chigurupati, Sridevi,Khan, Khalid Mohammed,Perveen, Shahnaz,Salar, Uzma,Shamim, Shahbaz,Taha, Muhammad,Ullah, Nisar,Ur Rehman, Ashfaq,Wadood, Abdul
, (2020/06/22)
(E)-3-(2-Benzylidenehydrazinyl)-5,6-diphenyl-1,2,4-triazines analogs 1–27 were synthesized by multi-step reaction scheme and subjected to in vitro inhibitory screening against α-amylase and α-glucosidase enzymes. Out of these twenty-seven synthetic analog
Multi-target inhibitors against Alzheimer disease derived from 3-hydrazinyl 1,2,4-triazine scaffold containing pendant phenoxy methyl-1,2,3-triazole: Design, synthesis and biological evaluation
Yazdani, Mahnaz,Edraki, Najmeh,Badri, Rashid,Khoshneviszadeh, Mehdi,Iraji, Aida,Firuzi, Omidreza
, p. 363 - 371 (2018/12/11)
Alzheimer's disease (AD) is a complex neurological disorder with diverse underlying pathological processes. Several lines of evidence suggest that BACE1 is a key enzyme in the pathogenesis of AD and its inhibition is of particular importance in AD treatme